John J Mason

Array ( [id] => 847208 [patent_doc_number] => 07384908 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-06-10 [patent_title] => 'Orally active peptides that prevent cell damage and death' [patent_app_type] => utility [patent_app_number] => 10/049587 [patent_app_country] => US [patent_app_date] => 2000-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 23 [patent_no_of_words] => 23235 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/384/07384908.pdf [firstpage_image] =>[orig_patent_app_number] => 10049587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 474882 [patent_doc_number] => 07226746 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-06-05 [patent_title] => 'Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease' [patent_app_type] => utility [patent_app_number] => 09/806842 [patent_app_country] => US [patent_app_date] => 1999-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 9979 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/226/07226746.pdf [firstpage_image] =>[orig_patent_app_number] => 09806842 [rel_patent_id] =>[rel_patent_doc_number] =>)